Studies on carcinoembryonic antigen levels in patients with adenocarcinoma of the uterus
- 1 December 1977
- Vol. 40 (6), 2953-2956
- https://doi.org/10.1002/1097-0142(197712)40:6<2953::aid-cncr2820400630>3.0.co;2-0
Abstract
Carcinoembryonic antigen was determined before treatment in 101 patients with adenocracinoma of the uterus. If 2.5 ng/ml is accepted as the upper normal value, 34% of the patients with cancer of the corpus had elevated levels. Only 7% had values exceeding 5 ng/ml. The highest recorded value in endometrial carcinoma was 8.5 ng/ml. In adenocarcinoma of the cervix 68% had values over 2.5 ng/ml and a direct correlation between nodal metastases and plasma elevation of CEA was found. The highest recorded value for endocervical cancer was 108 ng/ml. No patient with localized disease had a value over 4.0 ng/ml. It is concluded that adenocarcinomas of the cervix and corpus have different biological properties, and that in adenocarcinoma of the cervix determination of CEA is a reliable indicator of the extent of disease. Cancer 40:2953-2956, 1977.This publication has 7 references indexed in Scilit:
- Adenocarcinoma of the uterine cervixGynecologic Oncology, 1977
- Characterization and localization of carcinoembryonic antigen in a squamous cell carcinoma of the cervixGynecologic Oncology, 1976
- Carcinoembryonic antigen in patients with gynecologic malignanciesAmerican Journal of Obstetrics and Gynecology, 1975
- The role of radical hysterectomy in adenocarcinoma of the endometriumGynecologic Oncology, 1974
- Carcinoembryonic antigen (CEA) assayA laboratory adjunct in the diagnosis and management of cancerHuman Pathology, 1974
- Carcinoembryonic Antigen in Cancer of the Female Reproductive System Sequential Levels and Effects of Treatment*Australian and New Zealand Journal of Obstetrics and Gynaecology, 1973